178 related articles for article (PubMed ID: 32580680)
1. Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.
Liu F; Chen H; Chen T; Lau CS; Yu FX; Chen K; Chen HP; Pan RS; Chan GC; Zhang XY; Nie YJ
Lupus; 2020 Jul; 29(8):872-883. PubMed ID: 32580680
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
Cheng T; Ding S; Liu S; Li Y; Sun L
Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
[No Abstract] [Full Text] [Related]
3. Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.
Xu J; Chen J; Li W; Lian W; Huang J; Lai B; Li L; Huang Z
J Am Soc Nephrol; 2020 Jan; 31(1):54-65. PubMed ID: 31604808
[TBL] [Abstract][Full Text] [Related]
4. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.
Jang SG; Lee J; Hong SM; Kwok SK; Cho ML; Park SH
Rheumatology (Oxford); 2020 Jun; 59(6):1426-1438. PubMed ID: 31904843
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
7. CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL. Fas
Lee JH; Lee HK; Kim HS; Kim JS; Ji AY; Lee JS; Kim KS; Lee TY; Bae SC; Kim Y; Hong JT; Han SB
Lupus; 2018 Oct; 27(11):1854-1859. PubMed ID: 30139297
[TBL] [Abstract][Full Text] [Related]
8. Combined application of mesenchymal stem cells and different glucocorticoid dosing alleviates osteoporosis in SLE murine models.
Ding S; Ren T; Song S; Peng C; Liu C; Wu J; Chang X
Immun Inflamm Dis; 2024 Jun; 12(6):e1319. PubMed ID: 38888448
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1.
Chun W; Tian J; Zhang Y
Stem Cell Res Ther; 2021 Sep; 12(1):512. PubMed ID: 34563233
[TBL] [Abstract][Full Text] [Related]
11. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice.
Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J
Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells induced CD4+ T cell apoptosis in treatment of lupus mice.
Huang S; Wu S; Zhang Z; Deng W; Fan J; Feng R; Kong W; Qi J; Chen W; Tang X; Yao G; Feng X; Wang D; Chen H; Sun L
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):30-35. PubMed ID: 30409422
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.
Lee HK; Kim HS; Pyo M; Park EJ; Jang S; Jun HW; Lee TY; Kim KS; Bae SC; Kim Y; Hong JT; Yun J; Han SB
Theranostics; 2020; 10(22):10186-10199. PubMed ID: 32929342
[No Abstract] [Full Text] [Related]
16. Transplantation of Adipose Tissue-Derived Mesenchymal Stem Cells Prevents the Development of Lupus Dermatitis.
Choi EW; Shin IS; Song JW; Yun TW; Yang J; Choi KS; Seong JK
Stem Cells Dev; 2015 Sep; 24(17):2041-51. PubMed ID: 25941899
[TBL] [Abstract][Full Text] [Related]
17. [Combined mesenchymal stem cells and allogenic bone marrow transplantation in treatment of MRL/lpr mice].
Zhang GF; Zhang X; Dong GF
Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):754-7. PubMed ID: 19080203
[TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
19. Differential efficacy of human mesenchymal stem cells based on source of origin.
Collins E; Gu F; Qi M; Molano I; Ruiz P; Sun L; Gilkeson GS
J Immunol; 2014 Nov; 193(9):4381-90. PubMed ID: 25274529
[TBL] [Abstract][Full Text] [Related]
20. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
